RDGL insider trading
OTC Markets OTCQB HealthcareVIVOS INC: insider trade history from SEC Form 4 filings.
About VIVOS INC
Vivos Inc., a radiation oncology medical device company, engages in the development of yttrium-90-based precision radionuclide therapy devices for the treatment of non-resectable tumors in the United States. The company develops RadioGel, which is an injectable particle-gel for Precision Radionuclide Therapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals. It is also developing PLGA-g-PEG polymers; PrecisionGel, a hydrogel polymer platform for delivering active pharmaceutical ingredients and therapeutic agents; Duncan Chiller, a general laboratory equipment for non-water localized chilling; and other products under the Alpha-Gel, Beta-Gel, Gamma-Gel, and Peltier Chiller brands. The company was formerly known as Advanced Medical Isotope Corporation and changed its name to Vivos Inc. in December 2017. Vivos Inc. was incorporated in 1994 and is headquartered in Kennewick, Washington.
Company website: radiogel.com
RDGL insider activity at a glance
FilingIQ tracks 53 insider transactions for RDGL in filings since Nov 9, 2018. The most recent transaction is dated Sep 30, 2026.
Across the full history, 39 open-market purchases
and 2 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on RDGL insider trades is 62.8/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest RDGL Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for RDGL?
- FilingIQ tracks 53 Form 4 insider transactions for RDGL (VIVOS INC), covering filings from Nov 9, 2018 onwards. 11 of those are dated within the last 90 days.
- Are RDGL insiders net buyers or net sellers?
- Across the full Form 4 history for RDGL, 39 transactions (74%) were open-market purchases and 2 (4%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does RDGL insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
- What sector is RDGL in?
- VIVOS INC (RDGL) is classified in the Healthcare sector, specifically Medical Devices, with a current market capitalisation of $29.93M.
Methodology & sources
Every RDGL insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.